Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
ACARIX.ST
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q4.22
N/A
-0.08
vs -0.06
Q1.23
N/A
-0.04
vs -0.05
Q2.23
N/A
-0.05
vs -0.07
Q3.23
N/A
-0.04
vs -0.08
Q4.23
N/A
-0.03
vs -0.08
Q1.24
N/A
-0.02
vs -0.04
Q2.24
N/A
-0.02
vs -0.05
Q3.24
N/A
-0.02
vs -0.04
Q4.24
N/A
-0.01
vs -0.03
Q1.25
N/A
-0.01
vs -0.02
Sales Growth
YoY
Current
Estimates
Q2.23
-8%
1.5M vs 1.7M
Q3.23
+35%
1.6M vs 1.2M
Q4.23
-29%
1.2M vs 1.7M
Q1.24
-21%
1.6M vs 2M
Q2.24
+27%
2M vs 1.5M
Q3.24
-37%
993K vs 1.6M
Q4.24
+45%
1.7M vs 1.2M
Q1.25
+11%
1.7M vs 1.6M
Q2.25
-3%
1.9M vs 2M
Q3.25
+132%
2.3M vs 993K
Return on Equity
QoQ
Q2.23
-47%
-0.47
vs -0.45
Q3.23
-59%
-0.59
vs -0.47
Q4.23
-43%
-0.43
vs -0.59
Q1.24
-18%
-0.18
vs -0.43
Q2.24
-25%
-0.25
vs -0.18
Q3.24
-29%
-0.29
vs -0.25
Q4.24
-21%
-0.21
vs -0.29
Q1.25
-24%
-0.24
vs -0.21
Institutionnal Ownership
Forecast
2821%2026-Revenue
894%2026-EPS
-286%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Acarix AB (publ), a medical technology company, develops and commercializes diagnostic tests for cardiovascular diseases in Germany, Sweden, the Middle East, Switzerland, Austria, and internationally. The company offers CADScor System, a non-invasive and ultra-sensitive analytical device for the diagnosis of coronary artery disease. Acarix AB (publ) was founded in 2009 and is headquartered in Malmö, Sweden.
STO
Unprofitable
Unprofitable
-0.03Â ( -7.69%)
Relative Strenght
Volume Buzz
166%
Earning Acce
Yes
Dist 52w H.
34%Quote Panel
Key Metrics
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How ACARIX.ST compares to sector?